, Tracking Stock Market Picks
Enter Symbol:
Clovis Oncology Inc (CLVS) [hlAlert]

up 86.60 %

Clovis Oncology Inc (CLVS) upgraded to Buy with price target $50 by Stifel

Posted on: Thursday,  Jun 5, 2014  12:00 AM ET by Stifel

Stifel rated Buy Clovis Oncology Inc (NASDAQ: CLVS) on 06/05/2014, when the stock price was $40.77. Since
then, Clovis Oncology Inc has gained 86.61% as of 01/20/2016's recent price of $76.08.
If you would have followed this Stifel's recommendation on CLVS, you would have gained 86.6% of your investment in 594 days.

Clovis Oncology, Inc. (Clovis) is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. The Company also focuses on the treatment of specific subsets of cancer populations. During the year ended December 31, 2010, the Company was in the process of developing three product candidates for which it holds global marketing rights: CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine; CO-1686, an oral epidermal growth factor receptor (EGFR) mutant-selective inhibitor and CO-338, a poly ADP (Adenosine Diphosphate)-ribose polymerase (PARP) inhibitor.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/26/2015 8:25 AM Buy
74.15 90.00
as of 10/17/2014
1 Week up  8.59 %
1 Month up  5.43 %
3 Months up  33.12 %
1 YTD up  18.98 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/7/2014 9:25 AM Buy
57.42 75.00
6/5/2014 12:00 AM Buy
40.77 50.00
9/6/2013 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy